- Home
- FHB vs SIGA Comparison
FHB vs SIGA Comparison
Compare FHB & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FHB | SIGA |
|---|---|---|
| Founded | 1858 | 1995 |
| Country | United States | United States |
| Employees | N/A | 45 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 462.6M |
| IPO Year | 2016 | 1997 |
Fundamental Metrics
Financial Performance| Metric | FHB | SIGA |
|---|---|---|
| Price | $26.13 | $6.32 |
| Analyst Decision | Sell | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $27.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 374.9K |
| Earning Date | 01-30-2026 | 11-06-2025 |
| Dividend Yield | 4.00% | ★ 9.29% |
| EPS Growth | ★ 17.02 | N/A |
| EPS | ★ 2.05 | 1.03 |
| Revenue | ★ $824,314,000.00 | $172,249,641.00 |
| Revenue This Year | $12.21 | N/A |
| Revenue Next Year | $2.43 | $132.36 |
| P/E Ratio | $12.70 | ★ $6.27 |
| Revenue Growth | ★ 1.80 | N/A |
| 52 Week Low | $20.32 | $4.95 |
| 52 Week High | $28.28 | $9.62 |
Technical Indicators
Market Signals| Indicator | FHB | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 62.64 | 45.02 |
| Support Level | $25.88 | $6.13 |
| Resistance Level | $26.49 | $6.55 |
| Average True Range (ATR) | 0.51 | 0.21 |
| MACD | 0.11 | 0.13 |
| Stochastic Oscillator | 76.86 | 70.14 |
Price Performance
Historical ComparisonAbout FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.